From: Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
Study 4 | Controls (n = 42) | AD (n = 43) |
---|---|---|
Gender (male/female) | 1/3 | 1/3 |
Age (years) | 72.64 [6.29] | 74.17 [7.71] |
Clinical group, MMSE* | 29.24 [0.76] | 20.05 [4.31] |
AD Biomarkers | Â | Â |
Aβ40 [pg/ml] | 6690 [2139] | 6523 [1887] |
Aβ42 [pg/ml] | 770.6 [303.2] | 409.6 [130.2] |
t-Tau [pg/ml] | 365.3 [193.4] | 619.3 [200] |
p-Tau [pg/ml] | 50.81 [35.26] | 116.4 [42.97] |
Nlgn1signal ratio (F-7 ab) | 0.22 [0.11] | 0.17 [0.13] |